|
|
|
A BILL TO BE ENTITLED
|
|
AN ACT
|
|
relating to the dispensation of aesthetic pharmaceuticals by |
|
physicians. |
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
SECTION 1. Section 157.002(f), Occupations Code, is amended |
|
to read as follows: |
|
(f) Subsections (b) and (c) do not authorize a physician or |
|
a person acting under the supervision of a physician to keep a |
|
pharmacy, advertised or otherwise, for the retail sale of dangerous |
|
drugs, other than as authorized under Sections [Section] 158.003 |
|
and 158.004, without complying with the applicable laws relating to |
|
the dangerous drugs. |
|
SECTION 2. Chapter 158, Occupations Code, is amended by |
|
adding Sections 158.004 and 158.005 to read as follows: |
|
Sec. 158.004. DISPENSING OF AESTHETIC PHARMACEUTICALS. (a) |
|
In this section, "aesthetic pharmaceutical" means: |
|
(1) a drug listed in the aesthetic pharmaceutical |
|
group under Section 158.005; or |
|
(2) a drug that: |
|
(A) is not a controlled substance; |
|
(B) requires a prescription for dispensation; |
|
(C) has been listed with the federal Food and |
|
Drug Administration; and |
|
(D) is prescribed for the enhancement of an |
|
individual's appearance. |
|
(b) A physician licensed under this subtitle may dispense to |
|
that physician's patients an aesthetic pharmaceutical in excess of |
|
the patient's immediate needs without obtaining a license under |
|
Chapter 558. The physician may charge a fee for dispensing the |
|
aesthetic pharmaceutical. |
|
(c) Before dispensing an aesthetic pharmaceutical to a |
|
patient, a physician must inform the patient that the prescription |
|
for the aesthetic pharmaceutical may be filled at a pharmacy, if |
|
available at a pharmacy, or dispensed in the physician's office. |
|
(d) Each state and federal labeling and recordkeeping |
|
requirement applicable to the aesthetic pharmaceutical must be |
|
followed and documented. A record maintained under this section |
|
must be accessible as provided under state and federal law. |
|
(e) The board, with the advice of the Texas State Board of |
|
Pharmacy, shall adopt rules to govern the packaging, labeling, and |
|
dispensation of aesthetic pharmaceuticals by a physician under this |
|
section and reasonable fees as necessary to implement this section. |
|
A fee adopted under this subsection may not exceed a fee adopted |
|
under Section 554.006 for authorizing a pharmacist to dispense |
|
pharmaceuticals. |
|
Sec. 158.005. AESTHETIC PHARMACEUTICAL GROUP. The |
|
aesthetic pharmaceutical group consists of: |
|
(1) bimatoprost; |
|
(2) hydroquinone; |
|
(3) tretinoin; |
|
(4) metronidazole; and |
|
(5) tazarotene. |
|
SECTION 3. Section 563.051(d), Occupations Code, is |
|
amended to read as follows: |
|
(d) This section does not authorize a physician or a person |
|
acting under the supervision of a physician to keep a pharmacy, |
|
advertised or otherwise, for the retail sale of dangerous drugs, |
|
other than as authorized under Sections [Section] 158.003 and |
|
158.004, without complying with the applicable laws relating to the |
|
dangerous drugs. |
|
SECTION 4. The Texas Medical Board shall adopt rules for the |
|
implementation of Section 158.004, Occupations Code, as added by |
|
this Act, not later than March 1, 2014. |
|
SECTION 5. (a) Except as provided by Subsection (b) of this |
|
section, this Act takes effect immediately if it receives a vote of |
|
two-thirds of all the members elected to each house, as provided by |
|
Section 39, Article III, Texas Constitution. If this Act does not |
|
receive the vote necessary for immediate effect, this Act takes |
|
effect September 1, 2013. |
|
(b) Section 158.004, Occupations Code, as added by this Act, |
|
takes effect March 1, 2014. |